Management of heart failure with mildly reduced ejection fraction

Management of heart failure with mildly reduced ejection fraction

 

Heart Failure medication for mildly reduced ejection fraction (Ejection Fraction 41-49%)

No substantial RCT has been performed exclusively in Heart Failure medication for mildly reduced ejection fraction. Some of the pharmacological treatment options for patients with HFrEF may be considered for this cohort of patients (European Society of Cardiology Guidelines, 2021). This includes ACE inhibitors/Angiotensin II receptor blockers/neprilysin inhibitors, beta-blockers and mineralocorticoid receptor antagonists.

Diuretics should be offered if there are any signs of congestion.

ESC guidelines

Not found what you need? Search here:

(c) British Society for Heart Failure, 2022-
BSH banner